- Home
- XYF vs CSTL Comparison
XYF vs CSTL Comparison
Compare XYF & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYF
- CSTL
- Stock Information
- Founded
- XYF 2014
- CSTL 2007
- Country
- XYF China
- CSTL United States
- Employees
- XYF N/A
- CSTL N/A
- Industry
- XYF Finance: Consumer Services
- CSTL Medical Specialities
- Sector
- XYF Finance
- CSTL Health Care
- Exchange
- XYF Nasdaq
- CSTL Nasdaq
- Market Cap
- XYF 708.7M
- CSTL 697.9M
- IPO Year
- XYF 2018
- CSTL 2019
- Fundamental
- Price
- XYF $14.68
- CSTL $21.82
- Analyst Decision
- XYF
- CSTL Strong Buy
- Analyst Count
- XYF 0
- CSTL 6
- Target Price
- XYF N/A
- CSTL $37.67
- AVG Volume (30 Days)
- XYF 326.2K
- CSTL 449.5K
- Earning Date
- XYF 08-18-2025
- CSTL 11-03-2025
- Dividend Yield
- XYF 3.83%
- CSTL N/A
- EPS Growth
- XYF 41.77
- CSTL N/A
- EPS
- XYF 5.32
- CSTL N/A
- Revenue
- XYF $1,047,188,328.00
- CSTL $346,269,000.00
- Revenue This Year
- XYF N/A
- CSTL N/A
- Revenue Next Year
- XYF N/A
- CSTL N/A
- P/E Ratio
- XYF $2.63
- CSTL N/A
- Revenue Growth
- XYF 45.10
- CSTL 20.40
- 52 Week Low
- XYF $4.76
- CSTL $14.59
- 52 Week High
- XYF $20.36
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- XYF 51.01
- CSTL 51.42
- Support Level
- XYF $13.94
- CSTL $21.28
- Resistance Level
- XYF $14.60
- CSTL $24.74
- Average True Range (ATR)
- XYF 0.70
- CSTL 1.09
- MACD
- XYF 0.02
- CSTL -0.34
- Stochastic Oscillator
- XYF 51.88
- CSTL 15.61
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.